Citadel Advisors’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
178,300
-68,600
-28% -$102K ﹤0.01% 11430
2026
Q1
$378K Buy
246,900
+15,400
+7% +$20.2K ﹤0.01% 9936
2025
Q4
$287K Buy
231,500
+51,100
+28% +$71.6K ﹤0.01% 10243
2025
Q3
$364K Sell
180,400
-76,000
-30% -$139K ﹤0.01% 9894
2025
Q2
$462K Buy
256,400
+210,100
+454% +$405K ﹤0.01% 8819
2025
Q1
$98.6K Sell
46,300
-260,700
-85% -$888K ﹤0.01% 11489
2024
Q4
$1.19M Buy
307,000
+71,700
+30% +$571K ﹤0.01% 6655
2024
Q3
$2.38M Buy
235,300
+51,700
+28% +$336K ﹤0.01% 5205
2024
Q2
$826K Sell
183,600
-45,500
-20% -$462K ﹤0.01% 6990
2024
Q1
$3.43M Buy
229,100
+16,800
+8% +$277K ﹤0.01% 4567
2023
Q4
$3.08M Buy
212,300
+161,600
+319% +$1.96M ﹤0.01% 4600
2023
Q3
$698K Buy
50,700
+14,400
+40% +$260K ﹤0.01% 7345
2023
Q2
$797K Buy
36,300
+14,500
+67% +$454K ﹤0.01% 6936
2023
Q1
$676K Buy
21,800
+12,700
+140% +$158K ﹤0.01% 7658
2022
Q4
$76.7K Buy
+9,100
New +$77.6K ﹤0.01% 11572

Other funds holding BMEA

Citadel Advisors's BMEA Position: Q2 2026 in Review

Citadel Advisors reduced its Biomea Fusion (BMEA) stake by 93% in Q2 2026, selling an estimated $913K and leaving 44,916 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #12975.

Citadel Advisors first reported a position in BMEA in Q2 2021 and has held it in 17 quarters since. The position peaked at $4.02M in Q2 2022. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Citadel Advisors held 44,916 shares of Biomea Fusion worth $66K as of Q2 2026.
  • Citadel Advisors sold 611,901 Biomea Fusion shares in Q2 2026, an estimated $913K.
  • Biomea Fusion made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12975 holding.
  • Citadel Advisors first reported a position in Biomea Fusion in Q2 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Biomea Fusion position peaked at $4.02M in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.